Small interfering RNA for cancer treatment: overcoming hurdles in delivery

In many ways, cancer cells are different from healthy cells. A lot of tactical nano-based drug delivery systems are based on the difference between cancer and healthy cells. Currently, nanotechnology-based delivery systems are the most promising tool to deliver DNA-based products to cancer cells. Th...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Acta Pharm Sin B
المؤلفون الرئيسيون: Charbe, Nitin Bharat, Amnerkar, Nikhil D., Ramesh, B., Tambuwala, Murtaza M., Bakshi, Hamid A., Aljabali, Alaa A.A., Khadse, Saurabh C., Satheeshkumar, Rajendran, Satija, Saurabh, Metha, Meenu, Chellappan, Dinesh Kumar, Shrivastava, Garima, Gupta, Gaurav, Negi, Poonam, Dua, Kamal, Zacconi, Flavia C.
التنسيق: Artigo
اللغة:Inglês
منشور في: Elsevier 2020
الموضوعات:
Review
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC7714980/
https://ncbi.nlm.nih.gov/pubmed/33304780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2020.10.005
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة